🇺🇸 FDA
Patent

US 11478489

Selective accretion of cytoprotectant in radiation-sensitive tissues and uses thereof

granted A61KA61K31/661A61K45/06

Quick answer

US patent 11478489 (Selective accretion of cytoprotectant in radiation-sensitive tissues and uses thereof) held by The Board of Regents of the University of Texas System expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Oct 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/661, A61K45/06, A61P, A61P35/00